| Reference : Structure-based design of benzoxazoles as new inhibitors for D-alanyl-D-alanine ligase |
| Scientific journals : Article | |||
| Human health sciences : Public health, health care sciences & services | |||
| http://hdl.handle.net/2268/106777 | |||
| Structure-based design of benzoxazoles as new inhibitors for D-alanyl-D-alanine ligase | |
| English | |
| Tytgat, Isabelle [Université Catholique de Louvain - UCL > > Unité de Pharmacologie cellulaire et moléculaire > >] | |
| Vandevuer, Stéphane [Université Libre de Bruxelles - ULB > > Structure et fonction des membranes biologiques > >] | |
| Ortmans, Isabelle [Université Libre de Bruxelles - ULB > > structure et fonction des membranes biologiques > >] | |
| Sirockin, Finton [Ecole suprieure de biotechnologie de Strasbourg UMR 7104 > > Laboratoire de biologie et génomique structurales IGBMC > >] | |
| Colacino, Evelina [Université Catholique de Louvain - UCL > > Unité de chimie pharmaceutique et radiopharmacie > >] | |
| Van Bambeke, Françoise [Université Catholique de Louvain - UCL > > Unité de pharmacologie cellulaire et moléculaire > >] | |
Duez, Colette [Université de Liège - ULg > > Centre d'ingénierie des protéines >] | |
| Poupaert, Jacques H [Université Catholique de Louvain - UCL > > Unité de Chimie pharmaceutique et radiopharmacie > >] | |
| Tulkens, Paul M [Université Catholique de Louvain - UCL > > Unité de Pharmacologie cellulaire et moléculaire > >] | |
| Dejaegere, Annick [Ecole suprieure de biotechnologie de Strasbourg UMR 7104 > > Laboratoire de Biologie et Génomique structurales, IGBMC > >] | |
Prévost, Martine [Université Libre de Bruxelles - ULB > > Structure et fonction des membranes biologiques > >] | |
| 16-Sep-2009 | |
| QSAR & Combinatorial Science | |
| Wiley | |
| 28 | |
| 11-12 | |
| 1394-1404 | |
| International | |
| 1611-020X | |
| 1611-0218 | |
| Weinheim | |
| Germany | |
| [en] Drug Design ; antibiotics ; D-Ala-D-Ala-Ligase | |
| [en] d-Alanyl – d-alanine ligase is an enzyme which catalyzes the dimerization of d-alanine,
and, as such, has an essential role in bacterial cell wall biosynthesis. It has been shown that inhibition of d-alanyl – d-alanine ligase prevents bacterial growth. d-Alanyl – d-alanine ligase represents therefore a viable antimicrobial target. The 3D structure of this enzyme complexed with a phosphinophosphate inhibitor has been reported, which allows for structure-based design studies. Four softwares (LUDI, MCSS, Autodock, and Glide) developed either for fragment or full-molecule docking were compared and scored for their ability to position in the active site four prototypic ligands: two inhibitors, i.e. a phosphinophosphate derivative and d-cycloserine, d-alanine and d-alanyl – d-alanine. Best performances were obtained with Glide and MCSS. A short series of novel derivatives based on a 2-phenylbenzoxazole scaffold was designed de novo on the basis of computational data. The best compound was found to fully inhibit the d-alanyl – d-alanine ligase of E. faecalis with an IC50 of 400 mM. | |
| Fonds de la Recherche Scientifique (Communauté française de Belgique) - F.R.S.-FNRS-PAI P5/33-FRSM3.4.597.06.CNRS.INSERM | |
| Researchers ; Professionals | |
| http://hdl.handle.net/2268/106777 | |
| 10.1002/qsar.200910054 |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.